BASFBAS
BAS logo
Fair Value
€52.55
Share price09 Jul
€51.671.7% undervalued intrinsic discount
Loading
1Y7.51%
7D1.02%

Asset Sales Momentum And Recovery Outlook Will Shape Ag Unit’s Market Debut

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
07 Nov 24
Updated
09 Jul 26
Views
568
Not Invested

Last Update 09 Jul 26

Fair value Increased 8.35%

BAS: AI Plastics And Bio-Based Ingredients Will Shape Balanced Medium-Term Outlook

The analyst fair value estimate for BASF has shifted from €48.50 to about €52.55, reflecting a series of recent price target revisions in the €40 to €60 range as analysts factor in updated assumptions on discount rates, revenue growth, profit margins, and P/E expectations.

Analyst Commentary

Recent research on BASF shows a mixed but generally constructive tone, with several firms adjusting price targets into the €40 to €60 band and updating their models for discount rates, revenue assumptions, margins, and P/E expectations.

Bullish Takeaways

  • Bullish analysts are lifting price targets into the mid to upper €50s and as high as €60. This supports the idea that BASF could justify a higher fair value if it executes against current earnings and cash flow assumptions.
  • Some bullish views are tied to company specific benefits from external factors such as the Strait of Hormuz close. These analysts factor this into higher earnings estimates and, in turn, support higher target prices.
  • Several target revisions upward by bullish analysts suggest confidence that BASF can sustain or improve profitability assumptions that underpin current P/E expectations.
  • With upgrades in rating alongside raised targets, bullish analysts appear more comfortable that current execution and the balance of risks are aligned with a higher valuation range for the stock.

Bearish Takeaways

  • JPMorgan maintains an Underweight rating despite raising its price target to €40. This signals that some analysts still see BASF as fully valued or less attractive compared with alternatives, even after revising assumptions.
  • Price target cuts from earlier higher levels, such as a move from €61 to €58, show that certain bearish analysts are taking a more cautious stance on how much value they are willing to assign to BASF within their models.
  • The spread between lower targets around €40 and upper targets around €60 highlights uncertainty around execution and future earnings, which can limit how much multiple expansion some bearish analysts are prepared to assume.
  • Retention of cautious ratings alongside raised targets indicates that, for some in the bearish camp, revised assumptions on revenue and margins improve the story but not enough to shift their overall view on risk reward.

What’s in the News for BASF

  • BASF introduced new bio based personal care and fragrance ingredients that use biotechnology and green chemistry, reinforcing its focus on sustainable product development and environmental stewardship across operations. (Source: BASF Launches Bio Based Beauty Ingredients As EPA Clears Wyandotte Plan)
  • The U.S. Environmental Protection Agency approved a comprehensive remediation plan for BASF’s Wyandotte, Michigan site, authorizing construction of groundwater barriers, extraction and on site treatment systems to prevent contaminants from entering the Detroit River. (Source: BASF Launches Bio Based Beauty Ingredients As EPA Clears Wyandotte Plan; Key Developments)
  • BASF committed €1.1b as part of a €2.3b industry wide push into AI driven medical plastics, focusing on advanced AI reactor technology to support manufacturing developments in that segment. (Source: AI Investment Surges in Medical Plastics Industry with BASF Leading $2.3 Billion Push)
  • In partnership with Bota Biosciences, BASF launched SkinNexus Collag3n, a 100% human identical recombinant Collagen III fragment for the personal care market, developed using AI powered biofoundry tools and BASF’s cosmetic active ingredient expertise. (Source: Bota Biosciences and BASF Launch AI Driven Human-Identical Collagen III for Personal Care; Key Developments)
  • BASF Aroma Ingredients released Micadelva, a citrus fragrance ingredient containing 80% renewable carbon and designed as a non allergenic alternative to orange terpenes, supporting customers’ reformulation and sustainability goals. (Source: Key Developments)

Valuation Changes for BASF

  • Fair Value: The analyst fair value estimate for BASF has risen slightly from €48.50 to about €52.55.
  • Discount Rate: The discount rate used in models has fallen slightly from 6.44% to about 6.15%.
  • Revenue Growth: Forecast revenue growth has risen significantly from about 0.38% to roughly 3.78%.
  • Net Profit Margin: Assumed net profit margin has risen modestly from about 3.77% to around 4.21%.
  • Future P/E: The future P/E assumption has fallen moderately from about 21.28x to roughly 19.11x.
10 viewsusers have viewed this narrative update

Key Takeaways

  • Portfolio streamlining and divestments focus BASF on higher-margin, resilient segments, with upcoming IPOs and expansion in agricultural and advanced technologies.
  • Strategic cost savings, energy sourcing diversification, and the new China site enhance competitiveness, stability, and margin potential amid evolving market and regulatory trends.
  • Prolonged low margins, structural challenges in Europe, execution risks in divestitures, and rising sustainability costs threaten profitability and could limit financial improvement for BASF.

Catalysts

About BASF
    Operates as a chemical company worldwide.
What are the underlying business or industry changes driving this perspective?
  • BASF is executing on portfolio optimization by divesting lower-growth businesses (Decorative Paints, Coatings) and preparing to IPO its high-margin Agricultural Solutions division by 2027, which should unlock value, streamline the portfolio toward higher-margin segments, and boost group-level earnings resilience and net margins.
  • Significant cost-savings programs (targeting €2.1 billion annual savings by end of 2026), alongside the completion of the major China Verbund investment (with project costs under budget and CapEx falling below depreciation from 2026), will meaningfully improve operating leverage and free cash flow, with cost competitiveness directly supporting improved net margins.
  • Expansion in Agricultural Solutions and Surface Technologies-segments benefiting from structural drivers such as sustainable food production, green mobility, and tighter emissions standards-are expected to deliver higher, more stable revenues and margin accretion, especially as secular demand for advanced agri-inputs and catalysts increases.
  • BASF's forward-secured and diversified long-term energy sourcing through new Equinor and Cheniere supply agreements reduces exposure to European gas price volatility and lowers the carbon footprint of its European production, enhancing operational resilience, cost structure, and long-term net margins as decarbonization pressures mount.
  • The Zhanjiang Verbund site in South China (commissioning end of 2025) strategically positions BASF for growth in the world's largest chemicals market and is expected to drive top-line growth and scale-based margin gains over time as local market overcapacity normalizes and regional infrastructure demand recovers.
BASF Earnings and Revenue Growth

BASF Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming BASF's revenue will grow by 3.8% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 2.6% today to 4.2% in 3 years time.
  • Analysts expect earnings to reach €2.8 billion (and earnings per share of €3.34) by about July 2029, up from €1.5 billion today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting €3.8 billion in earnings, and the most bearish expecting €2.2 billion.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 19.1x on those 2029 earnings, down from 27.2x today. This future PE is lower than the current PE for the GB Chemicals industry at 25.6x.
  • Analysts expect the number of shares outstanding to decline by 1.21% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 6.15%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Persistently low margins and overcapacity in the global base chemicals market-particularly highlighted by the new Zhanjiang Verbund site in China-could weigh on group profitability for several years, impacting both revenue growth and net margins.
  • Weakness in European operations, especially ongoing structural challenges and possible asset closures at the Ludwigshafen site, indicate a prolonged negative demand trend in Europe; this could depress earnings, elevate restructuring costs, and erode overall group cash flow.
  • Flat to declining chemical market growth outside China, and muted global demand coupled with heightened uncertainty among customers, suggest risk of prolonged stagnation in sales volumes and suppressed group-wide EBITDA in key segments.
  • High reliance on successful execution of divestitures and portfolio optimization-particularly the sale of Coatings and potential IPO of Agricultural Solutions-carries execution risk; delays or lower-than-expected valuations could constrain planned deleveraging and limit improvement in financial health.
  • Rising capital expenditure requirements for decarbonization, cost inflation, and sector-wide regulatory pressures around sustainability and emissions may compress returns and require ongoing restructuring, potentially offsetting operational efficiency gains and diminishing future net earnings.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of €52.55 for BASF based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €63.0, and the most bearish reporting a price target of just €40.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €66.1 billion, earnings will come to €2.8 billion, and it would be trading on a PE ratio of 19.1x, assuming you use a discount rate of 6.2%.
  • Given the current share price of €47.62, the analyst price target of €52.55 is 9.4% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on BASF?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Comments

0 comments

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

€52.55
vs €51.671.7% undervalued intrinsic discount
PastFuture-2b86b2015201820212024202620272029Revenue €66.1bEarnings €2.8b
3.8%
Revenue growth
4.2%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on BASF

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Fair value with acceptable track record.

Market cap€44.5b
PB1.2x
Estimated Growth2.5%
Dividend Yield4.4%
Full analysis

CEO & management

Markus Kamieth
CEO
3.3yrs
CEO Tenure

Operates as a chemical company worldwide.